Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy
Closed for comments This consultation ended on at Request commenting lead permission
4 Evaluation committee members and NICE project team
Evaluation committee members
The 4 technology appraisal evaluation committees are standing advisory committees of NICE. This topic was considered by committee A.
Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
Chair
Jane Adam
Chair, Technology appraisal evaluation committee
NICE project team
Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser and a project manager.
Thomas Jarratt
Technical lead
Zoe Charles
Technical adviser
Thomas Feist
Project manager
ISBN: [to be added at publication]
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation